MARKET

BVS

BVS

Bioventus Inc.
NASDAQ
3.980
-0.090
-2.21%
After Hours: 3.950 -0.03 -0.75% 17:42 04/26 EDT
OPEN
4.080
PREV CLOSE
4.070
HIGH
4.090
LOW
3.950
VOLUME
128.40K
TURNOVER
0
52 WEEK HIGH
6.08
52 WEEK LOW
0.8600
MARKET CAP
315.08M
P/E (TTM)
-1.3582
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BVS last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at BVS last week (0408-0412)?
Weekly Report · 04/15 09:13
Weekly Report: what happened at BVS last week (0401-0405)?
Weekly Report · 04/08 09:13
Weekly Report: what happened at BVS last week (0325-0329)?
Weekly Report · 04/01 09:13
Weekly Report: what happened at BVS last week (0318-0322)?
Weekly Report · 03/25 09:13
Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading
Atrion Corporation is a healthcare company focused on fluid delivery products. The company has experienced a decline in revenue, profits, and cash flows. The stock is currently expensive compared to similar companies. Despite the potential for improvement in the future, the company is overvalued. Atrion has been downgraded to a 'sell' rating.
Seeking Alpha · 03/24 12:34
Weekly Report: what happened at BVS last week (0311-0315)?
Weekly Report · 03/18 09:13
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
Shares of Blend Labs, Inc. (NASDAQ:BLND) rose sharply after the company reported fourth-quarter financial results. Blend Labs shares jumped 24.3% to $2.92 on Friday. The Dow Jones index fell around 100 points in today's session.
Benzinga · 03/15 14:25
More
About BVS
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.

Webull offers Bioventus Inc stock information, including NASDAQ: BVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BVS stock methods without spending real money on the virtual paper trading platform.